Evidence map›Paper›PMID 42789213›Full record

ArticleHuman cell2026

Dynamic flow-driven in vitro skin model reveals mechanosensitive remodeling pathways.

Kazunari Sugita, Mitsuko Nakashima, Shuhei Iwamoto, Shigehisa Aoki

Abstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kazunari SugitaDivision of Dermatology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan. sugita@cc.saga-u.ac.jp.ORCID http://orcid.org/0000-0002-4808-3437
Mitsuko NakashimaDivision of Dermatology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
Shuhei IwamotoDivision of Pathology, Department of Pathology and Microbiology, Faculty of Medicine, Saga University, Saga, Japan.
Shigehisa AokiDivision of Pathology, Department of Pathology and Microbiology, Faculty of Medicine, Saga University, Saga, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanical forces regulate skin biology, yet few in vitro systems replicate pathological remodeling under physiological stress. We developed a three-dimensional co-culture model of HaCaT keratinocytes and NIH-3T3 fibroblasts embedded in collagen matrices, subjected to continuous unidirectional fluid flow to mimic physiological mechanical stress. Epidermal organization, fibroblast responses, and mechanosensitive signaling were assessed by histology, immunohistochemistry and western blotting. Fluid flow markedly enhanced keratinocyte stratification, with increased cytokeratin 14 and involucrin expression. A similar increase in keratinocyte thickness was observed in the co-culture system using TIG-121 fibroblasts. Ki-67 staining revealed elevated keratinocyte proliferation, particularly under co-culture conditions. Fibroblast density increased with flow without altering dermal thickness, accompanied by a trend toward α-SMA expression. ERK and p38 MAPK pathways were selectively activated in flow-stimulated co-cultures. This fluidic skin model recapitulates key cellular and molecular responses to mechanical stress and provides a platform for investigating mechanoresponsive pathways in the skin.

Indexed as

FibroblastsKeratinocytesMechanotransduction, CellularModels, BiologicalSkinSkin Physiological PhenomenaStress, MechanicalAnimalsCell ProliferationCoculture TechniquesHumansMAP Kinase Signaling SystemMiceNIH 3T3 CellsFluid flowMAPK signalingMechanical stressSkin co-culture model

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.